A Source Control Model for Treatment-Resistant Substance Use Disorder.

IF 4.2 3区医学 Q1 SUBSTANCE ABUSE Journal of Addiction Medicine Pub Date : 2024-09-01 Epub Date: 2024-07-15 DOI:10.1097/ADM.0000000000001344

Matthew Robert Dernbach, Karen Drexler, Elizabeth McCord, Joseph E Carpenter

引用次数: 0

Abstract

Abstract: We propose applying the "source control" model of infectious disease treatment to the management of treatment-resistant substance use disorder (SUD). We believe that this conceptual framework complements other models for understanding SUD, fills a gap in our current understanding of treatment-resistant SUD, and advances the destigmatization of SUD by reinforcing SUD as a disease similar to other medical conditions. The model also harmonizes the need for multimodal treatment and novel interventions for both acute supportive care and long-term treatment of SUD. In this manuscript, we discuss the justification for, as well as the strengths and limitations of, the "source control" model for the management of treatment-resistant SUD. We also discuss the model's potential to direct innovative research questions and therapeutic interventions.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

治疗耐药性药物使用障碍的源头控制模型。

摘要：我们建议将传染病治疗的 "源头控制 "模式应用于耐药性药物使用障碍（SUD）的管理。我们认为，这一概念框架补充了其他理解药物滥用障碍的模式，填补了我们目前对耐药药物滥用障碍理解的空白，并通过强化药物滥用障碍是一种与其他病症类似的疾病，推进了药物滥用障碍的去污名化。该模型还协调了急性支持性护理和长期治疗 SUD 对多模式治疗和新型干预措施的需求。在本手稿中，我们讨论了采用 "源头控制 "模式来管理耐药性药物依赖性障碍的理由、优势和局限性。我们还讨论了该模式在指导创新性研究问题和治疗干预措施方面的潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Addiction Medicine 医学-药物滥用

CiteScore

6.10

自引率

9.10%

发文量

260

审稿时长

>12 weeks

期刊介绍： The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including: •addiction and substance use in pregnancy •adolescent addiction and at-risk use •the drug-exposed neonate •pharmacology •all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances •diagnosis •neuroimaging techniques •treatment of special populations •treatment, early intervention and prevention of alcohol and drug use disorders •methodological issues in addiction research •pain and addiction, prescription drug use disorder •co-occurring addiction, medical and psychiatric disorders •pathological gambling disorder, sexual and other behavioral addictions •pathophysiology of addiction •behavioral and pharmacological treatments •issues in graduate medical education •recovery •health services delivery •ethical, legal and liability issues in addiction medicine practice •drug testing •self- and mutual-help.